CALF_News_Feb_March_2019

17 CALF News • February | March 2019 • www.calfnews.net – ANOTHER MORNING OF – Chances are, you’re on the short list of folks who know that cattle are excellent secret keepers, especially when it comes to letting anyone know they have the symptoms of BRD. But there’s another list you should find yourself on – the people who know about Zuprevo ® (tildipirosin) . This is an easy-to-use, cost-effective way to not only slow the growth of bacteria like H. somnus that cause BRD, but stop it altogether. Find BRD. Fix BRD. Zuprevo. To find out more, talk to your Merck Animal Health rep or text FIX to 48109 to see our video. By texting, you agree to receive text messages fromMerck Animal Health where you will receive offers and reminders. Up to six messages per month. You can opt out at any time by replying STOP to 48109. Text message and data rates may apply. merck-animal-health-usa.com • 800-521-5767 Copyright ©2018 Intervet Inc., doing business as Merck Animal Health, a subsidiary of Merck & Co., Inc. All rights reserved. 2/18 BV-ZUP-FEED-56199-TEXT FOR USE IN ANIMALS ONLY. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. TO AVOID ACCIDENTAL INJECTION, DO NOT USE IN AUTOMATICALLY POWERED SYRINGES WHICH HAVE NO ADDITIONAL PROTECTION SYSTEM. IN CASE OF HUMAN INJECTION, SEEK MEDICAL ADVICE IMMEDIATELY AND SHOW THE PACKAGE INSERT OR LABEL TO THE PHYSICIAN. DO NOT USE Zuprevo ® 18% IN SWINE. Fatal adverse events have been reported following the use of tildipirosin in swine. NOT FOR USE IN CHICKENS OR TURKEYS. Cattle intended for human consumption must not be slaughtered within 21 days of the last treatment. Do not use in female dairy cattle 20months of age or older. Use of this drug product in these cattle may cause milk residues. Awithdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal. The effects of Zuprevo ® 18% on bovine reproductive performance, pregnancy and lactation have not been determined. Swelling and inflammation, whichmay be severe, may be seen at the injection site after administration. Subcutaneous injection may result in local tissue reactions which persist beyond slaughter withdrawal period. This may result in trim loss of edible tissue at slaughter. Brief summary available on adjacent page. IMPORTANT SAFETY INFORMATION